FUCOSIDOSIS REVISITED - A REVIEW OF 77 PATIENTS

被引:118
作者
WILLEMS, PJ
GATTI, R
DARBY, JK
ROMEO, G
DURAND, P
DUMON, JE
OBRIEN, JS
机构
[1] IST GIANNIAN GASLINI,DEPT MOLEC GENET,GENOA,ITALY
[2] IST GIANNIAN GASLINI,DEPT PEDIAT,GENOA,ITALY
[3] STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305
[4] STANFORD UNIV,MED CTR,SCH MED,DEPT GENET,STANFORD,CA 94305
[5] UNIV CALIF SAN DIEGO,DEPT NEUROSCI,SAN DIEGO,CA 92103
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 1991年 / 38卷 / 01期
关键词
FUCOSIDASE; OLIGOSACCHARIDOSIS; LYSOSOMAL STORAGE DISORDER; REVIEW STUDY;
D O I
10.1002/ajmg.1320380125
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Fucosidosis is a rare, autosomal recessive, lysosomal storage disorder caused by a severe deficiency of alpha-L-fucosidase in all tissues. We have conducted a review of fucosidosis, compiling data from published reports and an international questionnaire survey. Seventy-seven patients affected with fucosidosis of which 19 had not been reported before have been identified. A major aim of the present study was to define the natural history of fucosidosis. The clinical picture of fucosidosis consists of progressive mental (95%) and motor (87%) deterioration, coarse facies (79%), growth retardation (78%), recurrent infections (78%), dysostosis multiplex (58%), angiokeratoma corporis diffusum (52%), visceromegaly (44%), and seizures (38%). Whereas the original fucosidosis patients described by Durand et al. (J. Pediatr 75:655-674, 1969) were decerebrate and died before age 5 years, most fucosidosis patients have a slower course of degeneration. Mortality before age 5 years was observed in only 7 patients (9%), whereas 36 patients (64%) reached the second decade. We did not find evidence for the existence of clinical heterogeneity with a rapidly progressive type I and a slowly progressive type II fucosidosis as suggested in the literature. Instead, there seems to exist a wide continuous clinical spectrum. At the biochemical level no heterogeneity in residual fucosidase enzyme activity or cross-reacting immunoreactive fucosidase protein was observed. At the DNA level at least 4 different mutations must be responsible for fucosidosis. These genotypic differences however do not explain the observed phenotypic differences.
引用
收藏
页码:111 / 131
页数:21
相关论文
共 155 条
[121]  
Staal G E, 1978, Monogr Hum Genet, V10, P56
[122]   FUCOSIDOSIS AND LEWIS SUBSTANCES [J].
STAAL, GEJ ;
VANDERHEIJDEN, MCM ;
TROOST, J ;
MOES, M ;
BORSTEILERS, E .
CLINICA CHIMICA ACTA, 1977, 76 (01) :155-157
[123]   STRUCTURE OF 3 MAJOR FUCOSYL-GLYCOASPARAGINES ACCUMULATING IN URINE OF A PATIENT WITH FUCOSIDOSIS [J].
STRECKER, G ;
FOURNET, B ;
MONTREUIL, J ;
DORLAND, L ;
HAVERKAMP, J ;
VLIEGENTHART, JFG ;
DUBESSET, D .
BIOCHIMIE, 1978, 60 (08) :725-734
[124]  
STRECKER G, 1977, CR ACAD SCI D NAT, V284, P85
[125]  
STRECKER G, 1981, LYSOSOMES LYSOSOMAL, P95
[126]   DIGESTION OF ASPARAGINE-LINKED OLIGOSACCHARIDES BY ENDO-BETA-N-ACETYLGLUCOSAMINIDASE IN THE HUMAN-SKIN FIBROBLASTS OBTAINED FROM FUCOSIDOSIS PATIENTS [J].
TACHIBANA, Y ;
YAMASHITA, K ;
KAWAGUCHI, M ;
ARASHIMA, SI ;
KOBATA, A .
JOURNAL OF BIOCHEMISTRY, 1981, 90 (05) :1291-1296
[127]  
TACONIS WK, 1976, RADIOL CLIN, V45, P258
[128]  
TAYLOR RM, 1986, LANCET, V2, P772
[129]  
TAYLOR RM, 1987, TRANSPLANT P, V19, P2730
[130]  
TAYLOR RM, 1988, TRANSPLANT P, V20, P89